Related Experiment Video
Updated: Feb 4, 2026
Quantification of Tumor Cell Adhesion in Lymph Node Cryosections
Published on: February 9, 2020
Clinically relevant somatic variants and genomic discordance between primary tumors and mediastinal lymph nodes in
Caroline Silvério Faria1, Camila Machado Baldavira2, Tabatha Gutierrez Prieto2
1Laboratorio de Investigacao Medica, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
Background:
Histopathological evaluation, TNM classification, and mediastinal staging via endobronchial ultrasound-guided transbronchial needle aspiration provide essential guidance for therapeutic decision-making in non-small cell lung cancer (NSCLC). Genomic profiles of primary tumors (PT) and matched mediastinal lymph nodes (MLN) can uncover occult metastases, refine recurrence risk assessment, and support personalized treatment strategies in lung adenocarcinoma (LUAD).
Objectives:
The study aimed to investigate clinically relevant somatic variants in formalin-fixed, paraffin-embedded (FFPE) PT and scrapings of MLN cytological slide samples using next-generation sequencing (NGS) and correlated the findings with overall survival (OS).
Design:
We retrospectively analyzed the genomic profile of PT and MLN from Brazilian LUAD patients between 2013 and 2020.
Methods:
Genomic DNA (gDNA) was extracted from PT and MLN matched samples of 32 patients (n = 64). Targeted NGS was performed using the SureSelect XTHS2 panel. We analyzed OS using Kaplan-Meier curves, and risk factors for mortality using univariate and multivariate Cox regression models.
Results:
Clinically significant or potentially significant variants were identified in 72% of PT and 75% of MLN, totaling 46 and 51 variants, respectively. The most frequent variants in PT involved EGFR (39.3%), TP53 (28.6%), ATM, and KRAS (21.4% in both), whereas in MLN, EGFR (35.7%), TP53 (32.1%), KRAS and BRAF (14.3% in both), and ATM (10.7%) have predominated. Co-mutations were detected in 31.3% of PT and 43.8% of MLN, with variant discordance between PT-MLN in 82.2% of cases.
Conclusion:
Cox regression analysis demonstrated that the presence of co-mutations in MLN was a co-factor associated with poorer OS, while no significant associations were observed for PT variants. These findings highlight distinct genomic profiles between PT and MLN. Integrating the molecular profile of MLN into staging may improve prognostic accuracy and guide treatment decisions in LUAD patients.
More Related Videos
08:01Non-surgical Intratracheal Instillation of Mice with Analysis of Lungs and Lung Draining Lymph Nodes by Flow Cytometry
Published on: May 2, 2011
08:29Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
Published on: October 2, 2014
Related Concept Videos
01:23Detailed Structure and Function of Lymph Nodes
From a histological perspective, lymph nodes can be split into two main areas: the superficial cortex and the deep medulla. The outer cortex is populated by dendritic cells, macrophages, and B lymphocytes, which are densely packed into follicles. When these B-lymphocytes are presented...
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
02:30Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
02:30Histone Variants at the Centromere
02:02Genomics
03:21Genome Size and the Evolution of New Genes